ViroPharma calls $79 million 6% convertibles due 2007

By Angela McDaniels

Seattle, Jan. 26 - ViroPharma Inc. said it will call all of its outstanding $79 million 6% convertible subordinated notes due March 2007 on March 1.

ViroPharma will pay 100.857% plus interest accrued to but excluding the redemption date.

A notice of redemption will be sent to all registered noteholders by trustee The Bank of New York (800 254-2826).

By redeeming the notes early, ViroPharma estimated it will reduce its annual interest expense by about $4 million over the remaining one-year life of the notes.

Exton, Pa.-based ViroPharma develops and markets drugs for the treatment of viral diseases such as cytomegalovirus and hepatitis C.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.